ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

ClinicalTrials.gov ID: NCT01467427

Public ClinicalTrials.gov record NCT01467427. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Study identification

NCT ID
NCT01467427
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
25 participants

Conditions and interventions

Interventions

  • nonacog beta pegol Drug

Drug

Eligibility (public fields only)

Age range
0 Years to 12 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 15, 2012
Primary completion
Nov 16, 2023
Completion
Nov 16, 2023
Last update posted
Dec 22, 2025

2012 – 2023

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
Children's Hospital Los Angeles - Endocrinology Los Angeles California 90027
UC Davis Medical Center Sacramento California 95817
Colorado Hemophilia & Thrombosis Center Aurora Colorado 80045
Childrens National Medical Ctr Washington D.C. District of Columbia 20010-2978
University of Miami Hospital & Clinics Miami Florida 33136
Emory University_Atlanta_1 Atlanta Georgia 30322
Augusta University Augusta Georgia 30912
University Of Iowa Iowa City Iowa 52242
University Of Louisville_Louisville_0 Louisville Kentucky 40202
Johns Hopkins University_Baltimore_3 Baltimore Maryland 21205
Children's Hospital of Michigan Detroit Michigan 48201
Children's Hospitals And Clinics Of Minnesota Minneapolis Minnesota 55404
The Children's Mercy Hospital Kansas City Missouri 64108-4619
Univ of NE Med Center_Omaha Omaha Nebraska 68198
Rutgers-Robert Wood Johnson Medical School New Brunswick New Jersey 08901
Maimonides Medical Center Brooklyn New York 11220
Mount Sinai Medical Center New York New York 10029
Univ Hosp Cleveland Med Ctr Cleveland Ohio 44106
Nationwide Children's Hospital Columbus Ohio 43205
Dayton Children Hemostati Ctr Dayton Ohio 45404
Univ Oklahoma Sci Ctr OK City Oklahoma City Oklahoma 73104
Children's Hosptl Philadelphia Philadelphia Pennsylvania 19104
Vanderbilt Hemostasis Thrombosis Clinic Nashville Tennessee 37232
Children's Medical Center_Dallas Dallas Texas 75235
Texas Children's Hospital_Houston Houston Texas 77030
Univ TX Hlth Sci Ctr Houston Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01467427, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01467427 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →